E-LIB Suche - Ergebnisse für: Miyahara, Yoshihiro

1

Preclinical evaluation of a novel CAR-T therapy utilizing a..:

Wang, Linan ; Matsumoto, Masahiro ; Akahori, Yasushi...
Molecular Therapy. 32 (2024) 3 - p. 734-748 , 2024

Link: https://doi.org/10.1016/..

2

Safety and Efficacy of NY-ESO-1 Antigen-Specific T-Cell Rec..:

Kawai, Akira ; Ishihara, Mikiya ; Nakamura, Tomoki...
Clinical Cancer Research. 29 (2023) 24 - p. 5069-5078 , 2023

Link: https://doi.org/10.1158/..

3

A phase 1 trial of NY‐ESO‐1‐specific TCR‐engineered T‐cell ..:

Ishihara, Mikiya ; Nishida, Yoshihiro ; Kitano, Shigehisa...
International Journal of Cancer. 152 (2023) 12 - p. 2554-2566 , 2023

Link: https://doi.org/10.1002/..

4

Fully closed cell sorter for immune cell therapy manufactur..:

Matsumoto, Masahiro ; Tashiro, Shinji ; Ito, Tatsumi...
Molecular Therapy - Methods & Clinical Development. 30 (2023) - p. 367-376 , 2023

Link: https://doi.org/10.1016/..

5

IL-17A Is the Critical Cytokine for Liver and Spleen Amyloi..:

Iida, Shohei ; Nakanishi, Takehisa ; Momose, Fumiyasu...
International Journal of Molecular Sciences. 23 (2022) 10 - p. 5726 , 2022

Link: https://doi.org/10.3390/..

6

Chimeric antigen receptor T-cell therapy targeting a MAGE A..:

Okumura, Satoshi ; Ishihara, Mikiya ; Kiyota, Naomi...
BMJ Open. 12 (2022) 11 - p. e065109 , 2022

Link: https://doi.org/10.1136/..

7

NY-ESO-1-specific redirected T cells with endogenous TCR kn..:

Ishihara, Mikiya ; Kitano, Shigehisa ; Kageyama, Shinichi...
Journal for ImmunoTherapy of Cancer. 10 (2022) 6 - p. e003811 , 2022

Link: https://doi.org/10.1136/..

8

Safety and antibody immune response of CHP-NY-ESO-1 vaccine..:

Ishikawa, Takeshi ; Kageyama, Shinichi ; Miyahara, Yoshihiro...
Cancer Immunology, Immunotherapy. 70 (2021) 11 - p. 3081-3091 , 2021

Link: https://doi.org/10.1007/..

9

First-in-human phase I clinical trial of the NY-ESO-1 prote..:

Ishihara, Mikiya ; Tono, Yasutaka ; Miyahara, Yoshihiro...
Cancer Immunology, Immunotherapy. 69 (2020) 4 - p. 663-675 , 2020

Link: https://doi.org/10.1007/..

10

Relationship between T cell receptor clonotype and PD‐1 exp..:

Sukegawa, Kenta ; Shitaoka, Kiyomi ; Hamana, Hiroshi...
European Journal of Immunology. 50 (2020) 10 - p. 1580-1590 , 2020

Link: https://doi.org/10.1002/..

11

MAGE-A4, NY-ESO-1 and SAGE mRNA expression rates and co-exp..:

Ishihara, Mikiya ; Kageyama, Shinichi ; Miyahara, Yoshihiro...
BMC Cancer. 20 (2020) 1 - p. , 2020

Link: https://doi.org/10.1186/..

12

First Case of Cytokine Release Syndrome after Nivolumab for..:

Oda, Hiroyasu ; Ishihara, Mikiya ; Miyahara, Yoshihiro...
Case Reports in Oncology. 12 (2019) 1 - p. 147-156 , 2019

Link: https://doi.org/10.1159/..

13

Development of INSOL‐tag for proteome‐wide protein handling..:

Fukuda, Eriko ; Mori, Masatoshi ; Shiku, Hiroshi...
Genes to Cells. 25 (2019) 1 - p. 41-53 , 2019

Link: https://doi.org/10.1111/..

14

NY-ESO-1 antigen expression and immune response are associa..:

Ueda, Shugo ; Miyahara, Yoshihiro ; Nagata, Yasuhiro...
Oncotarget. 9 (2018) 89 - p. 35997-36011 , 2018

Link: https://doi.org/10.18632..

15

Pertuzumab, trastuzumab and eribulin mesylate therapy for p..:

Tono, Yasutaka ; Ishihara, Mikiya ; Miyahara, Yoshihiro...
Oncotarget. 9 (2018) 19 - p. 14909-14921 , 2018

Link: https://doi.org/10.18632..